Ticker Scorecard - PBYI Basics Company: Puma Biotechnology Inc IPO Date: April 20, 2012 Sector: Healthcare Industry: Biotech Market Cap: $142.6M Activated in VL: True Average Daily Range Avg Daily Range: $1.29 | 3.13% Avg Daily Range (30 D): $0.07 | 2.34% Avg Daily Range (90 D): $0.09 | 3.09% Institutional Daily Volume Avg Daily Volume: .61M Avg Daily Volume (30 D): .41M Avg Daily Volume (90 D): .44M Trade Size Avg Trade Size (Sh.): 119 Avg Trade Size (Sh.) (30 D): 116 Avg Trade Size (Sh.) (90 D): 123 Institutional Trades Total Inst.Trades: 3,677 Avg Inst. Trade: $2.05M Avg Inst. Trade (30 D): $.58M Avg Inst. Trade (90 D): $.58M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $2.6M Avg Closing Trade (30 D): $.58M Avg Closing Trade (90 D): $.58M Avg Closing Volume: 76.87K     News Jul 18, 2024 @ 11:58 PM Puma Biotechnology executive sells over $9,600 in ... Source: Investing.Com Jul 3, 2024 @ 1:45 AM Puma biotech exec sells shares worth over $19,000 ... Source: Investing.Com Jul 3, 2024 @ 1:45 AM Puma Biotechnology executive sells over $14,000 in... Source: Investing.Com Jul 3, 2024 @ 1:45 AM Puma Biotechnology CFO sells shares worth over $17... Source: Investing.Com Jun 4, 2024 @ 3:01 PM Beyond The Numbers: 4 Analysts Discuss Puma Biotec... Source: Benzinga Insights Financials   TTM Q3 2024 Q2 2024 Basic EPS $.48 $.41 $-.09 Diluted EPS $.47 $.41 $-.09 Revenue $ 243.57M $ 80.54M $ 47.08M Gross Profit $ 168.76M $ 51.45M $ 36.43M Net Income / Loss $ 23.24M $ 20.32M $ -4.53M Operating Income / Loss $ 32.4M $ 22.08M $ -2.18M Cost of Revenue $ 74.81M $ 29.1M $ 10.66M Net Cash Flow $ -17.32M $ .11M $ -17.44M PE Ratio 6.18